These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19842409)

  • 21. Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression.
    Kirchhoff F; Greenough TC; Hamacher M; Sullivan JL; Desrosiers RC
    Virology; 1997 Jun; 232(2):319-31. PubMed ID: 9191845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans.
    Buttò S; Fiorelli V; Tripiciano A; Ruiz-Alvarez MJ; Scoglio A; Ensoli F; Ciccozzi M; Collacchi B; Sabbatucci M; Cafaro A; Guzmán CA; Borsetti A; Caputo A; Vardas E; Colvin M; Lukwiya M; Rezza G; Ensoli B;
    J Infect Dis; 2003 Oct; 188(8):1171-80. PubMed ID: 14551888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of human immunodeficiency virus type 1 CRF01_AE env genes derived from recently infected Thai individuals.
    Chaitaveep N; Utachee P; Nakamura S; Chuenchitra T; Ekpo P; Takeda N; Pattanapanyasat K; Kameoka M
    Microbes Infect; 2014 Feb; 16(2):142-52. PubMed ID: 24513704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of lysine residue at amino acid position 165 of human immunodeficiency virus type 1 CRF01_AE Gag in reducing viral drug susceptibility to protease inhibitors.
    Kameoka M; Isarangkura-na-Ayuthaya P; Kameoka Y; Sapsutthipas S; Soonthornsata B; Nakamura S; Tokunaga K; Sawanpanyalert P; Ikuta K; Auwanit W
    Virology; 2010 Sep; 405(1):129-38. PubMed ID: 20573365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Studies on HIV-1 strains in Henan province].
    Zhao F; Wang Z; Zhu Q; Cui ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):231-4. PubMed ID: 19642375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand.
    Pitisuttithum P; Gilbert P; Gurwith M; Heyward W; Martin M; van Griensven F; Hu D; Tappero JW; Choopanya K;
    J Infect Dis; 2006 Dec; 194(12):1661-71. PubMed ID: 17109337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads.
    Baeten JM; Chohan B; Lavreys L; Chohan V; McClelland RS; Certain L; Mandaliya K; Jaoko W; Overbaugh J
    J Infect Dis; 2007 Apr; 195(8):1177-80. PubMed ID: 17357054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Women infected with HIV type 1 Brazilian variant, subtype B (B'-GWGR motif) have slower progression to AIDS, compared with patients infected with subtype B (B-GPGR motif).
    de Brito A; Komninakis SC; Novoa P; de Oliveira RM; Fonseca LA; Duarte AJ; Casseb J
    Clin Infect Dis; 2006 Dec; 43(11):1476-81. PubMed ID: 17083025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 Tat-specific IgG antibodies in high-responders target a B-cell epitope in the cysteine-rich domain and block extracellular Tat efficiently.
    Kashi VP; Jacob RA; Paul S; Nayak K; Satish B; Swaminathan S; Satish KS; Ranga U
    Vaccine; 2009 Nov; 27(48):6739-47. PubMed ID: 19744585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of MIP-1beta and RANTES in HIV-1 subtype CRF01_AE infected patients with different rates of disease progression.
    Chuenchitra T; Wasi C; de Souza M; Nitayaphan S; Louisirirotchanakul S; Sutthent R; Brown AE; Birx DL; Polonis VR
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):856-62. PubMed ID: 19058580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological properties of HIV-1 subtype B' isolates from infected Chinese blood donors at different disease stages.
    Chen Y; Shen C; Wu H; Caruso L; Ratner D; Rodriguez M; Chen X; Gupta P
    Virology; 2009 Feb; 384(1):161-8. PubMed ID: 19058828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phylodynamic analysis of the dissemination of HIV-1 CRF01_AE in Vietnam.
    Liao H; Tee KK; Hase S; Uenishi R; Li XJ; Kusagawa S; Thang PH; Hien NT; Pybus OG; Takebe Y
    Virology; 2009 Aug; 391(1):51-6. PubMed ID: 19540543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of HIV-1 genetic diversity in China on the measurement of viral load.
    Wang Y; Song A; Xu S; Li X; Chong H; Zhao C; Nie J; Zhang C
    J Med Virol; 2008 Jan; 80(1):1-8. PubMed ID: 18041045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of HIV-1 subtype B and AE-specific neutralizing antibodies in mice and macaques with DNA prime and recombinant gp140 protein boost regimens.
    Center RJ; Wheatley AK; Campbell SM; Gaeguta AJ; Peut V; Alcantara S; Siebentritt C; Kent SJ; Purcell DF
    Vaccine; 2009 Nov; 27(47):6605-12. PubMed ID: 19712773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral, HLA and T cell elements in cross-reactive immune responses to HIV-1 subtype A, CRF01_AE and CRF02_AG vaccine sequence in Ivorian blood donors.
    Aidoo M; Sawadogo S; Bile EC; Yang C; Nkengasong JN; McNicholl JM
    Vaccine; 2008 Sep; 26(37):4830-9. PubMed ID: 18640166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Subtype of HIV-1 strains: an epidemic study of 1157 samples in Henan Province, China].
    Zhao F; Wang Z; Li WJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Jun; 42(6):418-21. PubMed ID: 19035044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on the molecular epidemiology of people infected with human immunodeficiency virus-1 in Shandong province].
    Fu JH; Li SZ; Zhang J; Liu XZ; Huang T; Xing H; Shao YM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Feb; 26(2):124-7. PubMed ID: 15921615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on gag-pol region characteristics of HIV-1 strains epidemic in Liaoning province].
    Han XX; Dai D; Zhang M; Wang YN; Jiang YJ; Shang H
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1966-70. PubMed ID: 17923034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Identification and characterization of HIV-1 subtype D strain in China].
    Xing H; Qin G; Feng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1999 Jun; 13(2):157-62. PubMed ID: 12569786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Association between sequence variation of Env, Gag genes from the same source and HIV-1 disease progression and host genetic polymorphism].
    Bai LS; Wang KL; Zhou GE; Meng B; Liu YC; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):153-5. PubMed ID: 17653321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.